Aim of our work was to study the histocompatibility antigen genes, HLA-A, B, C, DRB1 and DQB1, of Italian MM patients with dermatologic complications onset after lenalidomide treatment. Our study evidenced that patients having severe dermatologic complications (SJS and erythema multiforme) share HLA-DRB ∗ 1501 and HLA-DQB1 ∗ 0602, whereas patient with less severe dermatologic complications (urticaria) share HLADRB1 ∗ 1502 and HLA DQB1 ∗ 0601.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

ALLEGRA, Alessandro;ALONCI, Andrea;MUSOLINO, Caterina
2012

Abstract

Aim of our work was to study the histocompatibility antigen genes, HLA-A, B, C, DRB1 and DQB1, of Italian MM patients with dermatologic complications onset after lenalidomide treatment. Our study evidenced that patients having severe dermatologic complications (SJS and erythema multiforme) share HLA-DRB ∗ 1501 and HLA-DQB1 ∗ 0602, whereas patient with less severe dermatologic complications (urticaria) share HLADRB1 ∗ 1502 and HLA DQB1 ∗ 0601.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11570/1934771
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact